To print please click the icon below.
Betty R. Yu, M.S.
Patent Agenet
*Practice limited to proceedings before the U.S. Patent and Trademark Office
Professional Profile
Bar Admission
- U.S. Patent and Trademark Office, 2012
Education
-
M.S. (1987)
University of Maryland (Nutritional Biochemistry) -
B.S. (1984)
University of Maryland (Biochemistry)
Languages
- English
- Chinese (Mandarin and Shanghainese Dialects)
Publications
- Yu, Betty R., Co-Author, “Enamino-oxindole HIV Protease Inhibitors” 22 Bioorg. Med. Chem. Lett. 5078-5083 (2012)
- Yu, Betty R., Co-Author, “Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum,” 327 J. Mol. Biol. 173-181 (2003)
- Yu, Betty R., Co-Author, “Drug resistance mutations can affect dimer stability of HIV-1 protease at neutral pH,” 8 Protein Science 1702-1707 (1999).
- Yu, Betty R., Co-Author, “Kinetic characterization of RS-344, an HIV-1 protease inhibitor designed with a 'resistant repellent' core,” 4 Antiviral Therapy (1999).
- Yu, Betty R., Co-Author, “A new series of potent, orally bioavailable, non-peptidic cyclic sulfones as HIV-1 protease inhibitors,” 39(18) J. Am. Chem. Soc. 3431-3434 (1996)
- Yu, Betty R., Co-Author, “Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure,” 34 Biochemistry 9282-9287 (1995)
- Yu, Betty R., Co-Author, “Expression of growth-related genes during tumor progression in v-raf transformed rat liver epithelial cells,” 50 Cancer Research 7460-7467 (1990)
- Yu, Betty R., Co-Author, “Purification and characterization of UDP -GlcNAc:dolichol phosphate GlcNAc-1-phosphotransferase from bovine mammary gland,” 263 J. Biol. Chem. 15964-15972 (1988)
Professional Experience
- Scientific research experience: Sequoia Pharmaceutical, Inc., Tibotec Inc., and National Cancer Institute.
- Patent technology transfer experience: Office of Technology Transfer and Development, National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), National Institutes of Health (NIH).
Professional Membership
- American Intellectual Property Law Association
- Licensing Executives Society
- Chinese Biopharmaceutical Association
Presentations
- Yu, Betty R., Co-Author, “HIV PIs with Excellent resistance Profile,” 2008 Gordon research Conference on Medicinal Chemistry, New London, NH, August 2008.
- Yu, Betty R., Co-Author, “Antiviral Activity of SPI-256 against WT and MDR Strains,” 15th International HIV Drug Resistance Workshop, Sitges, Spain, June 2006.
- Yu, Betty R., Co-Author, “Highly potent HIV protease inhibitors with broad activity against MDR stains,” XIII International HIV Drug Resistance Workshop, Canary islands, Spain, June 2004.
- Yu, Betty R., First Author, “Development of a relational database for structure-based drug design,” RAMC 99 Conference, San Diego, CA, August 1999.
- Yu, Betty R., Co-Author, “Structures of plasmepsin II in complex with non-peptidic inhibitors,” VIII International Aspartic Proteinase Conference, September 1999.
- Yu, Betty R., Co-Author, “The not-so-great escape: Drug resistance studies with HIV protease,” 217th American Chemical Society National Meeting, Anaheim, CA, March 1999.
- Yu, Betty R., Co-Author, “Design and parallel synthesis of human cathepsin D inhibitor libraries,” 39th Annual Buffalo Medicinal Chemistry Symposium, May 1998.
- Yu, Betty, R., Co-Author, “Structural studies of drug resistance for HIV-1 protease mutants,” American Crystallographic Association, Montreal, Canada, July 1995.